| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015567489 |
| P356 | DOI | 10.2165/11597550-000000000-00000 |
| P698 | PubMed publication ID | 22233455 |
| P50 | author | Cédric Annweiler | Q30762971 |
| Olivier Beauchet | Q61628802 | ||
| P2860 | cites work | Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial | Q21203743 |
| Alzheimer's Disease | Q22248111 | ||
| Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond | Q22251042 | ||
| Cholinesterase inhibitors for Alzheimer's disease | Q22252975 | ||
| Memantine for dementia | Q22252980 | ||
| Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain | Q24320314 | ||
| Vitamin D deficiency | Q27860616 | ||
| Vitamin D, cognitive dysfunction and dementia in older adults | Q28244118 | ||
| Neuronal calcium signaling | Q29614727 | ||
| The role of neuroimaging in mild cognitive impairment | Q31136940 | ||
| Vitamin D and cognitive performance in adults: a systematic review. | Q33491244 | ||
| Vitamin D metabolism and action | Q33590614 | ||
| 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services | Q33601267 | ||
| Vitamin D and ageing: neurological issues. | Q33632088 | ||
| Vitamin D and risk of cognitive decline in elderly persons | Q33742161 | ||
| The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons | Q33847890 | ||
| Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis | Q33859664 | ||
| Microglia activation and anti-inflammatory regulation in Alzheimer's disease | Q33943873 | ||
| Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse | Q34007194 | ||
| Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures | Q34032447 | ||
| New clues about vitamin D functions in the nervous system | Q34118382 | ||
| Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity | Q34260540 | ||
| The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease | Q34268122 | ||
| Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function | Q34296896 | ||
| Glutamate: its role in learning, memory, and the aging brain | Q34319529 | ||
| Memantine: a review of its use in Alzheimer's disease | Q34557011 | ||
| Dietary intake of vitamin D and cognition in older women: a large population-based study. | Q48961401 | ||
| Vitamin D-mentia: randomized clinical trials should be the next step. | Q50978800 | ||
| Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice. | Q51016105 | ||
| Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. | Q51932318 | ||
| A Novel Perspective for Alzheimer's Disease: Vitamin D Receptor Suppression by Amyloid-β and Preventing the Amyloid-β Induced Alterations by Vitamin D in Cortical Neurons | Q52604567 | ||
| High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. | Q53225654 | ||
| Dementia: a problem for our age. | Q53320658 | ||
| L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue. | Q53339349 | ||
| Alzheimer's disease | Q55880664 | ||
| Profile of French community-dwelling older adults supplemented with vitamin D: Findings and lessons | Q56088923 | ||
| SEVERE VITAMIN D DEFICIENCY IS ASSOCIATED WITH ADVANCED-STAGE DEMENTIA IN GERIATRIC INPATIENTS | Q56088925 | ||
| 25-hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid | Q70230440 | ||
| Amyloid-beta promotes calcium influx and neurodegeneration via stimulation of L voltage-sensitive calcium channels rather than NMDA channels in cultured neurons | Q74736159 | ||
| Association between vitamin D receptor gene polymorphism and Alzheimer's disease | Q80528542 | ||
| Calcium signal transduction and cellular control mechanisms | Q81121812 | ||
| Early Alzheimer's trials: new developments | Q83816106 | ||
| [Vitamin D in the elderly: 5 points to remember] | Q84900344 | ||
| Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases | Q34606186 | ||
| Coupling of the NMDA receptor to neuroprotective and neurodestructive events | Q35012580 | ||
| 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier. | Q35183393 | ||
| Glutamatergic systems in Alzheimer's disease. | Q35218753 | ||
| Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits | Q35234934 | ||
| Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease | Q35246412 | ||
| Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store | Q35987301 | ||
| Glutamate-glutamine cycling in Alzheimer's disease | Q36671525 | ||
| Neurosteroid hormone vitamin D and its utility in clinical nutrition | Q36672359 | ||
| Vitamin D and human health: lessons from vitamin D receptor null mice. | Q36973933 | ||
| Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? | Q37023280 | ||
| Multi-target-directed ligands to combat neurodegenerative diseases | Q37052982 | ||
| Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease | Q37156208 | ||
| Presynaptic glutamate receptors: physiological functions and mechanisms of action. | Q37157515 | ||
| Neuronal glutamate and GABAA receptor function in health and disease | Q37631654 | ||
| Pre-dementia Alzheimer's trials: overview | Q37715753 | ||
| Memantine in dementia: a review of the current evidence | Q37850821 | ||
| Excitatory amino acid neurotoxicity and neurodegenerative disease | Q37989602 | ||
| Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes | Q38323931 | ||
| A radical hypothesis for neurodegeneration | Q40385988 | ||
| Developmental Vitamin D3 deficiency alters the adult rat brain. | Q40447667 | ||
| Vitamin D3 and brain development | Q40652918 | ||
| Does oxidative stress participate in nerve cell death in Parkinson's disease? | Q40848260 | ||
| Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats | Q40896377 | ||
| 1Alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells | Q41068068 | ||
| Nitric oxide actions in neurochemistry | Q41136024 | ||
| 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis | Q41703229 | ||
| Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease | Q42482311 | ||
| 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. | Q42552926 | ||
| 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis | Q43266202 | ||
| Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. | Q43517443 | ||
| Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture | Q43614886 | ||
| Cell biology. Apoptosis--the calcium connection. | Q44391381 | ||
| Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system | Q44391600 | ||
| 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. | Q44448707 | ||
| 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei | Q44545860 | ||
| NMDA application potentiates synaptic transmission in the hippocampus | Q44731160 | ||
| Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development | Q45089334 | ||
| Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. | Q45288480 | ||
| A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease | Q45883058 | ||
| 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. | Q46015814 | ||
| Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease | Q46575382 | ||
| 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. | Q48096904 | ||
| Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. | Q48524232 | ||
| 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis | Q48720312 | ||
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| vitamin | Q34956 | ||
| vitamin D | Q175621 | ||
| P304 | page(s) | 81-91 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Drugs & Aging | Q5308946 |
| P1476 | title | Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D. | |
| P478 | volume | 29 |
| Q36413548 | 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signaling |
| Q46584010 | Achillolide A Protects Astrocytes against Oxidative Stress by Reducing Intracellular Reactive Oxygen Species and Interfering with Cell Signaling |
| Q26795400 | Anti-dementia medications: current prescriptions in clinical practice and new agents in progress |
| Q37645117 | Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina |
| Q38620338 | Benefits and risks of add-on therapies for Alzheimer's disease |
| Q36719022 | Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia |
| Q39252599 | Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications |
| Q56088847 | Les effets neurocognitifs de la vitamine D chez la personne âgée |
| Q37559812 | Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease |
| Q34329204 | The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives |
| Q41652246 | Vitamin D is Not a Protective Factor in ALS. |
| Q37522446 | Vitamin D supplements: a novel therapeutic approach for Alzheimer patients |
| Q53353882 | [Vitamin D and Alzheimer's disease: from an intriguing idea to a therapeutic option]. |
Search more.